Position in NTLA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,428,292
+$2,112,712 QoQ
Shares Held
579,430
-2.0% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$21,205
PutShares
520
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. NTLA ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in NTLA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,428,292 | 579,430 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $5,315,580 | 591,277 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $867,834 | 50,251 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,002,136 | 426,667 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,420,649 | 340,457 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $5,112,420 | 438,458 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,062,739 | 246,362 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,932,026 | 131,011 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,049,907 | 74,515 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $6,407,808 | 210,161 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,584,264 | 208,231 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,960,582 | 195,208 | Shares | Defined | 2023-08-09 | |
| 2023-06-30 | $21,205 | 520 | Put | Defined | 2023-08-09 | |
| 2023-03-31 | $7,256,878 | 194,711 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,821,624 | 80,872 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,397,962 | 114,331 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $2,571,436 | 49,680 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,355,912 | 59,941 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $4,369,913 | 36,958 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,847,379 | 13,771 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $393,441 | 2,430 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $679,278 | 8,464 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $369,158 | 6,786 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $234,166 | 11,779 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $130,597 | 6,213 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $255,313 | 20,876 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||